IE34386B1 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
IE34386B1
IE34386B1 IE920/70A IE92070A IE34386B1 IE 34386 B1 IE34386 B1 IE 34386B1 IE 920/70 A IE920/70 A IE 920/70A IE 92070 A IE92070 A IE 92070A IE 34386 B1 IE34386 B1 IE 34386B1
Authority
IE
Ireland
Prior art keywords
pharmaceutical compositions
pharmaceutically acceptable
acceptable salt
acetylsalicylic acid
acid
Prior art date
Application number
IE920/70A
Other versions
IE34386L (en
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of IE34386L publication Critical patent/IE34386L/en
Publication of IE34386B1 publication Critical patent/IE34386B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1287433 Composition comprising acetylsalicylic acid BEECHAM GROUP Ltd 20 July 1970 [7 Aug 1969] 39610/69 Heading A5B A pharmaceutical composition contains as active ingredients acetylsalicylic acid or a pharmaceutically acceptable salt thereof and 4-chlorophenoxyacetic acid 2,2-diethylaminoethylamide or a pharmaceutically acceptable salt thereof. [GB1287433A]
IE920/70A 1969-08-07 1970-07-15 Pharmaceutical compositions IE34386B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB39610/69A GB1287433A (en) 1969-08-07 1969-08-07 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
IE34386L IE34386L (en) 1971-02-07
IE34386B1 true IE34386B1 (en) 1975-04-30

Family

ID=10410502

Family Applications (1)

Application Number Title Priority Date Filing Date
IE920/70A IE34386B1 (en) 1969-08-07 1970-07-15 Pharmaceutical compositions

Country Status (10)

Country Link
AT (1) AT297921B (en)
BE (1) BE754602A (en)
DE (1) DE2038792A1 (en)
ES (1) ES382438A1 (en)
FR (1) FR2068470B1 (en)
GB (1) GB1287433A (en)
IE (1) IE34386B1 (en)
LU (1) LU61447A1 (en)
NL (1) NL7011044A (en)
ZA (1) ZA704998B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668245A (en) * 1986-10-22 1987-05-26 Bankamerica Corporation Fuel additive for use in alcohol fuels
MX2019014773A (en) 2017-06-13 2020-02-07 Afecta Pharmaceuticals Inc Ccl2 inhibitors.

Also Published As

Publication number Publication date
NL7011044A (en) 1971-02-09
DE2038792A1 (en) 1971-02-18
GB1287433A (en) 1972-08-31
AT297921B (en) 1972-04-10
BE754602A (en) 1971-02-08
IE34386L (en) 1971-02-07
ZA704998B (en) 1971-04-28
ES382438A1 (en) 1973-04-16
LU61447A1 (en) 1970-10-05
FR2068470A1 (en) 1971-08-27
FR2068470B1 (en) 1974-02-22

Similar Documents

Publication Publication Date Title
CA994239A (en) Pesticidal compositions and a process for the preparation of active ingredients
CA985168A (en) Ingestible, topical and other compositions containing cyclohexanamide compounds
NZ195058A (en) 2b-acetoxymethyl-(5r)-2-methyl-penam-3-carboxylic acid 1, 1-dioxide and salts and esters thereof pharmaceutical compositions
GB1202148A (en) Pharmaceutical compositions
IE34386B1 (en) Pharmaceutical compositions
CA961041A (en) 1-methyl-3-alkoxymethyl-5,5-disub-stituted barbituric acid compounds and therapeutic compositions containing same
GB1261989A (en) 5-thiazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing the same
IE35507L (en) Preparations containing tetrahydrocarbazole¹derivatives
CA1008461A (en) 3,4-dihydroxyphenyl-alamines as active ingredients of antioxidant compositions
IL57218A (en) 9-deoxy-daunorubicin,9-deoxydoxorubicin,their acid addition salts,preparation thereof and pharmaceutical compositions comprising them
CA820860A (en) Pharmaceutical composition containing the hydrochloric acid addition salt of 2-amino-adamantane as active ingredient
CA953715A (en) N(6)-(2,5-dimethylbenzyl)-2-chloroadenosine derivatives, process for their preparation and pharmaceutical compositions containing the same
GB1261454A (en) Improved analgesic systems and compositions
DE2861571D1 (en) Amidines, their preparation and pharmaceutical compositions containing them.
IE41628L (en) Erythromycin pyroglutamate
CA941375A (en) 1,2,4-oxidiazole salt, a process for the preparation thereof and pharmaceutical composition comprising same
GB1509778A (en) Pharmaceutical composition and dosage units thereof
CA946374A (en) 17.beta.-HYDROXY-17.alpha.-(2'-METHALLYL)9.beta.,10.alpha.-ANDROSTA-1,4,6-TRIEN-3-ONE, METHODS OF PRODUCING THIS COMPOUND AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID COMPOUND AS AN ACTIVE INGREDIENT
IE32211L (en) Therapeutic compositions
CA1019765A (en) Salts of 2,6-dioxocyclohexane thiocarboxylic acid 4'-halo-anilides and pharmaceutical compositions thereof
GB1193438A (en) Barbituric Acid Derivatives, preparation thereof and Pharmaceutical Compositions containing them
CA945544A (en) 16-METHYLENE-9.beta., 10.alpha.-STEROID COMPOUNDS, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN THE NOVEL COMPOUNDS AS ACTIVE INGREDIENTS, AND METHODS OF PRODUCING THE SAID COMPOUNDSAND PREPARATIONS
GB1238709A (en)
CA804582A (en) PHARMACEUTICAL PREPARATIONS CONTAINING .alpha.-AMINO-.beta.-(3:4-DICHLOROPHENYL)-BUTYRIC ACID, OR ITS SALTS
AU456249B2 (en) Pharmaceutical compositions containing 4 hydroxynicotinic acid